Cargando…
Ten-Patient Trial: Remarkable Responses in Pediatric Cancers
A clinical trial of nivolumab in 10 patients with pediatric cancer with high tumor mutational burden demonstrated complete responses in 50% of patients. This result recapitulates multiple clinical trial results in high mutation–burden adult cancers and may redefine best practice in the setting of ge...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690083/ https://www.ncbi.nlm.nih.gov/pubmed/37733329 http://dx.doi.org/10.1158/1078-0432.CCR-23-2232 |